Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

  • Quoted phrase not found.
1.

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD.

Genet Med. 2015 Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18.

2.

The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.

Das U, Lakshmaiah KC, Govind Babu K, Suresh TM, Lokanatha D, Jacob L, Babu S.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1777-82. doi: 10.1007/s00432-014-1724-1. Epub 2014 Jun 4.

PMID:
24894013
3.

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Gray SW, Hornik RC, Schwartz JS, Armstrong K.

Clin Genet. 2012 Jan;81(1):29-37. doi: 10.1111/j.1399-0004.2011.01797.x. Epub 2011 Nov 2.

4.

Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.

Kwiatkowski F, Dessenne P, Laquet C, Petit MF, Bignon YJ.

Eur J Hum Genet. 2012 Feb;20(2):141-7. doi: 10.1038/ejhg.2011.169. Epub 2011 Sep 21.

5.
6.

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

Duffy DL, Antill YC, Stewart CJ, Young JP; kConFab, Spurdle AB.

Twin Res Hum Genet. 2011 Apr;14(2):111-8. doi: 10.1375/twin.14.2.111.

PMID:
21425892
7.

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.

Bruchim I, Amichay K, Kidron D, Attias Z, Biron-Shental T, Drucker L, Friedman E, Werner H, Fishman A.

Int J Gynecol Cancer. 2010 Oct;20(7):1148-53. doi: 10.1111/IGC.0b013e3181ef622d.

PMID:
21206239
8.

Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.

Kenkhuis MJ, de Bock GH, Elferink PO, Arts HJ, Oosterwijk JC, Jansen L, Mourits MJ.

Maturitas. 2010 Jul;66(3):310-4. doi: 10.1016/j.maturitas.2010.03.018. Epub 2010 Apr 21.

PMID:
20409655
9.

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1303-11. doi: 10.1158/1055-9965.EPI-08-0825. Epub 2009 Mar 24.

10.

Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.

Gates MA, Tworoger SS, Terry KL, De Vivo I, Hunter DJ, Hankinson SE, Cramer DW.

Int J Cancer. 2009 Feb 1;124(3):729-33. doi: 10.1002/ijc.23924.

11.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
12.

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.

Wakefield CE, Meiser B, Homewood J, Peate M, Taylor A, Lobb E, Kirk J, Young MA, Williams R, Dudding T, Tucker K; AGenDA Collaborative Group.

Breast Cancer Res Treat. 2008 Jan;107(2):289-301. Epub 2007 Feb 27.

PMID:
17333332
13.

Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.

Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, Raysor S, Popa-Mabe M.

J Health Commun. 2005;10 Suppl 1:119-36.

PMID:
16377604
14.

Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.

Stormorken AT, Hoff G, Norstein J, Bowitz-Lothe IM, Hanslien E, Grindedal E, Møller P.

Scand J Gastroenterol. 2006 Jan;41(1):71-9.

PMID:
16373279
15.

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN.

J Med Genet. 2005 Oct;42(10):749-55. Epub 2005 Mar 22.

16.
17.

Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

Marchetti P, Di Rocco CZ, Ricevuto E, Bisegna R, Cianci G, Calista F, Sidoni T, Porzio G, Ficorella C.

Ann Oncol. 2004;15 Suppl 1:I27-I34. Review.

18.

Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA.

Hill DA, Preston-Martin S, Ross RK, Bernstein L.

Cancer Causes Control. 2002 Oct;13(8):711-8.

PMID:
12420949
19.

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Skinner CS, Schildkraut JM, Berry D, Calingaert B, Marcom PK, Sugarman J, Winer EP, Iglehart JD, Futreal PA, Rimer BK.

Genet Test. 2002 Summer;6(2):93-105.

PMID:
12215248
20.

Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project.

Fries MH, Holt C, Carpenter I, Carter CL, Daniels J, Flanagan J, Murphy K, Hailey BJ, Martin L, Hume R, Hudson G, Cadman M, Weatherly R, Nunes ME.

Mil Med. 2002 Feb;167(2):93-8.

PMID:
11873549
Items per page

Supplemental Content

Loading ...
Write to the Help Desk